ATE206932T1 - Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln - Google Patents

Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln

Info

Publication number
ATE206932T1
ATE206932T1 AT98906986T AT98906986T ATE206932T1 AT E206932 T1 ATE206932 T1 AT E206932T1 AT 98906986 T AT98906986 T AT 98906986T AT 98906986 T AT98906986 T AT 98906986T AT E206932 T1 ATE206932 T1 AT E206932T1
Authority
AT
Austria
Prior art keywords
transfection agent
formulation
acid particles
cationic transfection
nuclic acid
Prior art date
Application number
AT98906986T
Other languages
English (en)
Inventor
Joel Crouzet
Bruno Pitard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE206932(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE206932T1 publication Critical patent/ATE206932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
AT98906986T 1997-02-10 1998-02-06 Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln ATE206932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
ATE206932T1 true ATE206932T1 (de) 2001-11-15

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98906986T ATE206932T1 (de) 1997-02-10 1998-02-06 Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln

Country Status (20)

Country Link
EP (1) EP1007097B1 (de)
JP (1) JP2001511171A (de)
KR (1) KR20000070914A (de)
AT (1) ATE206932T1 (de)
AU (1) AU737720B2 (de)
BR (1) BR9807563A (de)
CA (1) CA2278665A1 (de)
CZ (1) CZ282199A3 (de)
DE (1) DE69802102T2 (de)
DK (1) DK1007097T3 (de)
ES (1) ES2166146T3 (de)
FR (1) FR2759298B1 (de)
GR (1) GR3036919T3 (de)
HU (1) HUP0001720A3 (de)
IL (1) IL130765A0 (de)
NO (1) NO993825L (de)
PT (1) PT1007097E (de)
SK (1) SK282685B6 (de)
WO (1) WO1998034648A1 (de)
ZA (1) ZA981034B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
AU768542C (en) * 1998-04-08 2004-06-17 Celltech R & D Limited Lipids
CA2335393C (en) * 1998-07-20 2008-09-23 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
EP1309904A4 (de) * 2000-03-03 2006-03-29 Valentis Inc Verbesserte poloxamer- und polyoaminverbindungen zur nukleinsäureeinbringung
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CA2426582A1 (en) * 2000-10-20 2002-08-08 Valentis, Inc. Gene delivery formulations and methods for treatment of ischemic conditions
EP1232758A1 (de) * 2001-02-19 2002-08-21 Aventis Pasteur Polynukleotid-Formulierung für verbesserte intrazellulare Übertragung
WO2005120546A2 (en) * 2004-03-03 2005-12-22 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP2008531732A (ja) 2005-03-03 2008-08-14 ルバンス セラピュティックス インク． ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (de) * 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
DE69802102D1 (de) 2001-11-22
HUP0001720A3 (en) 2001-10-29
BR9807563A (pt) 2000-02-01
HUP0001720A1 (hu) 2000-09-28
CA2278665A1 (fr) 1998-08-13
CZ282199A3 (cs) 1999-10-13
SK108299A3 (en) 2000-05-16
ZA981034B (en) 1998-08-11
KR20000070914A (ko) 2000-11-25
ES2166146T3 (es) 2002-04-01
DK1007097T3 (da) 2002-02-11
FR2759298A1 (fr) 1998-08-14
PT1007097E (pt) 2002-04-29
NO993825D0 (no) 1999-08-09
EP1007097A1 (de) 2000-06-14
GR3036919T3 (en) 2002-01-31
AU6298798A (en) 1998-08-26
JP2001511171A (ja) 2001-08-07
WO1998034648A1 (fr) 1998-08-13
DE69802102T2 (de) 2002-03-14
IL130765A0 (en) 2001-01-28
NO993825L (no) 1999-08-09
EP1007097B1 (de) 2001-10-17
SK282685B6 (sk) 2002-11-06
FR2759298B1 (fr) 1999-04-09
AU737720B2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
ATE206932T1 (de) Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
FR2791895B1 (fr) Utilisation de trehalose pour stabiliser un vaccin liquide
PT1123120E (pt) Formulacao medicinal em aerossol
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
EP0911039A3 (de) Wirkstoff-Harzkomplexe stabilisiert mit Chelatbildner
NO954320L (no) Lyosfærer omfattende gonadotropin
ZA892399B (en) Pharmaceutical compositions of piroxicam in aqueous solution and process for their preparation
BR0207699A (pt) Produto para aplicação axilar
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
MXPA04001007A (es) Emulsion inversa que contiene dihidroepiandrosterona.
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
ZA903334B (en) Cleansing composition
DE69429252T2 (de) Fluessige arzneizusammensetzungen enthaltend ibuprofen
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
EP1385948A4 (de) Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon
TR199801460T2 (xx) Renk stabilize edici(ler) ve s�rfaktan(lar)� i�eren temizleyici bile�im.
ES2090170T3 (es) Agente de recubrimiento espermicida.
GR3020075T3 (en) Novel liquid compositions based on derivatives of 1,4 substituted piperidine
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
ATE110788T1 (de) In immunoassays verwendbare stabilisierte peroxidase-zusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee